(Q33809526)

English

Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study (English)

1 reference

Europe PubMed Central

29 July 2017

0 references

extracellular matrix

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

Karl Michaëlsson

object named as

Karl Michaëlsson

7

0 references

Ramachandran S. Vasan

object named as

Ramachandran S Vasan

2

0 references

4

object named as

Erik Ingelsson

1 reference

Europe PubMed Central

29 July 2017

Johan Sundström

8

object named as

Johan Sundström

1 reference

Europe PubMed Central

29 July 2017

3

object named as

Johan Ärnlöv

1 reference

Europe PubMed Central

29 July 2017

5

object named as

Lars Lind

1 reference

Europe PubMed Central

29 July 2017

6

object named as

Anders Larsson

1 reference

Europe PubMed Central

29 July 2017

author name string

Jonas Hansson

1

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

19 January 2011

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

6

1 reference

Europe PubMed Central

29 July 2017

1

1 reference

Europe PubMed Central

29 July 2017

e16185

1 reference

Europe PubMed Central

29 July 2017

copyright license

Creative Commons Attribution 4.0 International

19 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Metalloproteinases in development and progression of vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

How matrix metalloproteinases regulate cell behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Gelatinase B functions as regulator and effector in leukocyte biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

4 July 2018

Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Calculating measures of biological interaction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Unriddling the role of matrix metalloproteinases in human cerebral stroke.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Matrix metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in serum do not reflect the analytes circulating in blood

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016185

21 January 2018

Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

30 October 2018

TIMP1 and adverse prognosis in non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023803

30 October 2018

Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MMP inhibitors in cardiac diseases: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix Metalloproteinase Expression After Human Cardioembolic Stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide-Retargeted Adenovirus Encoding a Tissue Inhibitor of Metalloproteinase-1 Decreases Restenosis after Intravascular Gene Transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21283828

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0016185

1 reference

Europe PubMed Central

29 July 2017

2011PLoSO...616185H

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33809526&oldid=1869708189"